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1. Introduction 
Thyroid adenylate cyclase activity has been shown 
to increase in response to thyrotrophin (TSH), lead- 
ing to a rapid increase in intracellular adenosine 
3’,5’cyclic monophosphate (cyclic AMP), which is 
thought o mediate the intracellular response to TSH. 
This has been demonstrated in both thyroid slices 
[ 1,2] and in particulate membrane preparations [3,4]. 
Two types of thyroid stimulating autoantibodies 
(TSIg) have been detected in the serum of patients 
with Graves’ disease, long-acting thyroid stimulator 
(LATS) [5] and LATS-protector (LATS-P) [6]. These 
immunoglobulins may also stimulate adenylate cyclase 
resulting in cyclic AMP accumulation i thyroid 
cells. The stimulation of cyclic AMP production by 
TSIg has been clearly shown in thyroid slices 
[ 1,2,7,8] but there are conflicting reports of the 
effects of TSIg on the stimulation of adenylate cyclase 
in human thyroid membrane preparations [29,10]. 
We have shown that there is a factor in cell cytosol 
which enhances hormone-stimulated a enylate 
cyclase [1 I]. This factor shows little evidence of 
tissue specificity as cytosols derived from different 
tissues timulated adenylate cyclase activity as much 
as cytosols derived from the tissue of origin. The 
mode of action of this factor has been shown to be 
similar to the action of guanosine triphosphate (GTP), 
although characterisation a d partial purification of 
the factor have established that the factor is not free 
GTP [12]. 
Here we have investigated the effect of human 
thyroid cytosol, human platelet cytosol and GTP on 
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the ability of TSH and TSIg to stimulate human 
thyroid membrane adenylate cyclase activity. 
2. Methods and materials 
Human thyroid tissue was obtained at surgery and 
kept at 04°C. The tissue was chopped with a razor 
and then homogenised in lo-times its volume of 
0.25 M sucrose 20 mM Tris/HCl (pH 7.4) using a 
Polytron homogeniser for 3 X 10 s at medium speed. 
Further homogenisation was carried out with 
5 strokes of a loose fitting Dounce homogeniser. 
After centrifugation of the homogenate at 800 X g to 
remove tissue debris, the supernatant was further 
centrifuged at 10 000 X g for 15 min. The resulting 
pellet was either resuspended in 20 mM Tris/HCl 
(pH 7.4) with 0.25 M sucrose for immediate assay or 
stored at -7O’C in 0.25 M sucrose, 0.2 mM MgClz, 
1 mM EGTA in 25 mM Tris/HCl (pH 7.4) with 10% 
(v/v) dimethylsulphoxide . 
Adenylate cyclase activity was measured as in [ 131, 
and [32P]cyclic AMP was isolated according to [14]. 
Membrane protein concentrations were determined 
by method in [15]. Results are expressed as the 
mean + SEM of 3 experiments. 
Isolated thyroid cells were prepared from non- 
toxic goitre obtained at surgery. The tissue was 
chopped finely and washed with calcium magnesium 
free Dulbecco’s medium and then sequentially digested 
for four 30 min periods over 2 h using 0.25% dispase. 
Isolated cells were collected by centrifugation at 
500 X g for 10 min , washed twice with Ca , Mg-free 
Dulbecco’s medium and the fmalcell pellet resuspended 
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in 199 medium containing 15% foetal calf serum, 
0.02 M N-2hydroxyethylpiperazine N’-2ethane- 
sulphonic acid (Hepes) (pH 7.4) and 0.02% NaHC03, 
plated in 90 cm’ Petri dishes and grown to confluency 
in the same medium. 
Thyroid cytosol was prepared from cells which 
had been maintained in culture for 1 week, and 
passaged once. Petri dishes were washed free of cul- 
ture medium with sucrose buffer containing 0.25 M 
sucrose, 1 mM EDTA and 15 mM Tris/HCl (pH 7.4). 
The cells were scraped from the plate surfaces, 
suspended in the same buffer (0.5 ml/90 cm2 plate) 
and frozen with a mixture of solid CO2 and ethanol 
and then thawed at 37’C. This freeze-thawing was 
repeated twice to lyse the cells. Centrifugation of the 
resulting whole cell lysate at 10 000 X g for 10 min 
yielded a ‘cytosol’ preparation which was stable 
at -20°C. 
Platelet cytosol was prepared from 30 ml fresh 
blood mixed with 3 ml 3.8% citrate (w/v) 0.1 M 
EDTA and spun for 10 min at 150 X g at room tem- 
perature yielding platelet rich plasma (PRP) which 
was removed with a plastic pipette. PRP was further 
spun at 500 X g for 10 min at room temperature and 
the platelet pellet resuspended in 15 mM Tris/HCl 
(pH 7.4) with 1 mM EDTA and 140 mM NaCl. After 
a second spin at 500 X g for 10 min at room temper- 
ature the pellet was resuspended in -2-3 ml of 
0.25 M sucrose 10 mM Tris/HCl (pH 7.4) at 40°C and 
lysed by freeze-thawing as described. Lysates were 
centrifuged at 50 000 X g for 30 min to yield a 
cytosol preparation which was stored at -2O’C. 
LATS and LATS-P were obtained from sera from 
patients with Graves’ disease. Immunoglobulin G 
preparations of LATS were prepared from serum 
samples obtained from thyrotoxic patients [ 161. The 
potency of LATS-IgG was estimated by the bioassay 
[ 17 ] as modified [ 18 ] and was found to be 760 mU/ 
~1 Medical Research Council Reference standard B 
for LATS. 
[o~-~~P]ATP (0.5-30 Ci/mmol) and cyclic [c+~H] - 
AMP (20130 Ci mmol) were obtained from the 
Radiochemical Centre, Amersham. Bovine serum 
albumin (fraction V, powder) was obtained from 
Armour Pharmaceutical Co., Eastbourne and all other 
biochemicals from Boehringer Mannheim, London. 
Medium 199 was obtained from Gibco. 
Thyroid stimulating hormone (bovine pituitary) 
was obtained from Sigma, London. For experimental 
use, freshly weighed amounts of TSH were dissolved 
in a small known volume of assay buffer and used 
immediately. 
3. Results 
Platelet cytosol was used in the initial experiments 
because of the difficulties of obtaining a thyroid 
cytosol preparation which was not contaminated with 
extracellular fluid. Factors present in extracellular 
fluids have a non-specific inhibitory effect on adenylate 
cyclase activity [ 111. In subsequent experiments 
thyroid cells were maintained in culture and thyroid 
cytosol prepared from these cells. Neither platelet nor 
thyroid cytosol had any intrinsic adenylate cyclase 
activity. 
Preliminary experiments showed that the ability 
of platelet cytosol to enhance TSH-stimulated adenyl- 
ate cyclase activity was greater if the membrane pellet 
was resuspended irectly in cytosol and both were 
present at the initiation of the response rather than if 
the membranes and cytosol were added to the assay 
separately. Consequently, in the following experi- 
ments, the membrane pellet was resuspended irectly 
in buffer, cytosol or GTP and used to start the reac- 
tion. In the limited number studied, membranes 
prepared from non-toxic goitres were more sensitive 
to TSH than membranes from toxic goitres and normal 
thyroid tissue. The following results are all based on 
preparations derived from non-toxic goitres. Figure 1 
shows theeffect ofGTP(10” M) and platelet cytosol 
on the response of the membrane preparation to TSH. 
Membranes in buffer showed an -6-fold stimulation 
of adenylate cyclase activity over basal in response to 
the maximum TSH concentration used. In the presence 
of GTP and in the presence of cytosol there was again 
a 6-fold stimulation of adenylate cyclase activity in 
response to TSH, although the rate of cyclic AMP 
production was much greater in both cases. Neither 
GTP nor cytosol significantly altered the fluoride- 
stimulated enzyme activity. Preliminary experiments 
indicate that the cytosol factor has no effect on the 
concentration of TSH needed to cause half maximal 
adenylate cyclase response. 
Table 1 shows that platelet cytosol increased the 
response to TSH and only in the presence of cytosol 
was there a significant response to LATS-IgG. The 
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Fig.1. Adenylate cyclase activity in membranes obtained 
from a non-toxic goitre in response to TSH (1 - 1000 nU//.d). 
The period of incubation with TSH was 10 mln at 37’C. 
Effect of platelet cytosol(20 pg cytosol protein/100 ~1 
incubation mixture) and GTP (lOeL M) on the rate of pro- 
duction of cyclic AMP. 
effect of the platelet cytosol could not be mimicked The discrepancy in the results of studies of mem- 
by GTF’. These results have since been repeated in a branes and slices can possibly be explained by the loss 
non-toxic goitre obtained from another patient. of a factor(s) during the preparation of thyroid mem- 
Table 2 shows the effects of thyroid cytosol and of branes, which is present in slices. We have shown that 
thyroid cytosol that had been extensively dialysed on a factor in cell cytosol which is not hormone, species 
the response to TSH and LATS-IgG. Cytosol increased or tissue specific enhances hormone-stimulated 
the response to TSH and only in the presence of adenylate cyclase activity [ 121. Consequently, the 
cytosol was there a significant increase in adenylate 
cyclase activity in response to LATS-IgG. This effect 
of cytosol was retained on dialysis. 
4. Discussion 
The action of the thyroid stimulating immuno- 
globulins on the thyroid has been well studied with 
regard to release of 12’1 from a pre-labelled human 
thyroid in vivo [ 191, uptake of 13rI by the thyroid in 
thyrotoxicosis [20] and colloid droplet formation in 
human thyroid slices [21] in response to TSIg. The 
action of TSIg has been studied in human thyroid 
membranes [22] using binding studies in which TSIg 
displaced TSH from membranes; such studies imply 
that the binding sites of TSH and TSIg may be iden- 
tical or closely adjacent. The binding of TSIg and 
subsequent stimulation of adenylate cyclase by TSIg 
in human thyroid slices has been shown [ 1,2,7 $1 but 
the situation in thyroid membranes is not so clear. 
Binding of TSIg has been clearly demonstrated in 
thyroid membranes [22] but the activation of adenyl- 
ate cyclase has not been consistent suggesting that the 
binding of TSIg is not always synonymous with the 
stimulation of adenylate cyclase. 
Table 1 
The effect of GTP (10e6 M) and platelet cytosol(20 ng cytosolic protein/100 ~1 
incubation mixture) on the adenylate cyclase response to TSH and LATS-IgG 
in a membrane preparation from a non-toxic goitre 
(pmol CAMP produced/mg membrane protein) 
+ Sucrose buffer + Platelet cytosol +GTP 
Basal 138+ 4.2 265 f 17 134kll 
TSH (1 mU/pl) 957 f 25 2147 + 17 911+ 46 
LATS-IgG 173 f 33 626 r 21a 160 f 31 
a Significantly different from basal value (P < 0.001) by t test 
Incubation period of 10 mln at 37’C with both TSH (1 mU/nl) and LATS-IgG 
(760 mU/pl MRC reference standard B for LATS). The mean + SEM (n=3) are 
shown 
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Table 2 
The effect of thyroid cytosol and dialysed thyroid cytosol on the adenylate cyclase 
response to TSH (1 mU/nl) and LATS-IgG (760 mU/nl) 
(pmol CAMP produced/mg membrane protein) 
+ Sucrose buffer + Thyroid cytosol + Dialysed thyroid 
cytosol 
Basal 38.8 * 3.0 73.7 + 4.7 51.9 + 3.0 
TSH (1 mU/crl) 367 f 29.0 640 + 4.3 572 f 11.7 
LATS-IgG 33.5 + 5.0 111.2 + 2.3a 134 f 3.3b 
Significantly different from basal: a (P < 0.01); b (P < 0.001) by t test 
Cytosol was dialysed for 24 h against several changes of sucrose buffer in which the cytosol 
was prepared. Incubation period of 10 min at 37°C. The mean f SEM are shown 
effects of human thyroid and platelet cytosols on the 
adenylate cyclase response to TSH and TSIg were 
studied. Our results indicate that a lack of response to 
TSIg may be due to the loss of some factor present in 
cell cytosol which occurs during the preparation of 
membranes. This factor is unlikely to be free GTP as 
the effect persisted after extensive dialysis of the 
cytosol and could not be mimicked by the addition 
of GTP to the assay. 
In conclusion, the addition of a cell cytosol 
preparation to the membranes can affect human 
thyroid adenylate cyclase responsiveness to both TSIg 
and TSH in vitro and may be relevant to the action of 
TSIg in vivo . 
Acknowledgements 
This work was supported by grants from the 
Medical Research Council and the Wellcome Trust. 
Dr S. Tomlinson is in receipt of a Wellcome Senior 
Research Fellowship in Clinical Science. We are 
grateful to Mr C. H. Talbot and Mr S. F. Tindall for 
their help in providing the thyroid tissue used in this 
study. We would like to thank Linda Chivers and 
Hazel Humphries for the LATS and LATSP IgG 
preparations and Stuart Johnson and Hooshang 
Amirrasooli for the preparations of platelet cytosol. 
References 
[ 1 ] Holmes, S., Martin, T. J., Dirmikis, S. and Munro, D. S. 
(1978) Clin. Sci. Mol. Med. 54,35P-36P. 
[ 21 Holmes, S., Dirmikis, S., Martin, T. J. and MUNO, D. S. 
(1978) J.Endocrinol. 79,121-130. 
272 
[3] Moore, W. V. and Wolff, J. (1974) J. Biol.‘Chem. 249, 
6255-6263. 
(41 Rees Smith, B., Pyle, G. A., Petersen, V. B. and Hall, R. 
(1977) J. Endocrinol. 75,391-400. 
[S] Adams, D. D. and Purves, H. D. (1956) Proc. Univ. 
Otago Medical School 34,11-12. 
[6] Adams, D. D. and Kennedy,T. H. (1967) J. Clin. 
Endocrinol. 27,173. 
[ 71 Holmes, S. D., Dirmikis, S. M., Martin, T. J. and MUNO, 
D. S. (1979) J. Endocrinol. 80,215-221. 
[8] Kendall-Taylor, P. (1973) Brit. Med. J. 3,72-75. 
[9] Orgiazzi, J., Williams, D. E., Chopra, I. J. and Solomon, 
D. H. (1976) J. Clin. Endocrinol. Metab. 42,341-354. 
[lo] Beck, K. and Nistrup Madsen, S. (1979) Clin. Endo- 
crinol. 11,47-58. 
[ 111 Johnson, S. K., MacNeil, S., Amirrasooli, H. and 
Tomlinson, S. (1979) J. Endocrinol. 81,15OP-15lP. 
[ 121 Crawford, A., MacNeil, S., Amirrasooli, H., Johnson, S., 
[I31 
[I41 
1151 
1161 
1171 
11’31 
[W 
1201 
1211 
WI 
Pollock, A. and Tomhnson, S. (1979) Proc. 7th Int. 
Cong. Endocrinology, in press. 
Hunt, N. H., Martin,T. J., Michelangeli, V. P. and 
Eisman, J. A. (1976) J. Endocrinol. 69,401-412. 
Salomon, Y., Londos, C. and Rodbell, M. (1974) Anal. 
Biochem. 58,541-548. 
Hartree,E. F. (1972) Anal. Biochem. 48,422-427. 
Carneiro, L., Dorrington, K. J. and Munro, D. S. (1966) 
Clin. Sci. 31,215-221. 
McKenzie, J. M. (1958) Endocrinology 63,372-382. 
Dirmikis, S. and MUNO, D. S. (1974) J. Endocrinol. 63, 
427-438. 
Adams, D. D., Fastier, F. N., Howie, J. B., Kennedy, 
T. H.,Kilpatrick, J. A. and Stewart, R. D. H. (1974) 
J. Clin. Endocrinol. Metab. 39,826-832. 
Adams,D.D.,Kennedy,T.H.andStewart,R.D.H. 
(1974) Brit. Med. J. 2,199-201. 
Shishiba, Y., Shimizu,T.,Yoshimura, S. and Shizume, 
K. (1973) J. Clin. Endocrinol. Metab. 36,517-521. 
Rees Smith, B., Pyle, G. A., Petersen, V. B. and Hall, R. 
(1977) J.Endocrinol. 75,401-407. 
